|
Volumn 33, Issue SUPPL. 4, 2001, Pages
|
Development, acceptance, and use of immunologic correlates of protection in monitoring the effectiveness of combination vaccines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
VACCINE;
ANIMAL MODEL;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION FUNCTION;
DRUG EFFICACY;
DRUG MONITORING;
DRUG SCREENING;
IMMUNE RESPONSE;
IMMUNOGENICITY;
IMMUNOLOGICAL MEMORY;
INFECTION PREVENTION;
LEGAL ASPECT;
LICENSING;
MEDICAL ETHICS;
MOUSE;
MUCOSAL IMMUNITY;
NONHUMAN;
PRIORITY JOURNAL;
VACCINE PRODUCTION;
ANIMALS;
ANTIBODIES, BACTERIAL;
BACTERIAL INFECTIONS;
BLOOD BACTERICIDAL ACTIVITY;
CLINICAL TRIALS;
HAEMOPHILUS INFECTIONS;
HUMANS;
IMMUNITY, CELLULAR;
IMMUNOLOGIC MEMORY;
MENINGOCOCCAL VACCINES;
MICE;
PNEUMOCOCCAL VACCINES;
PRODUCT SURVEILLANCE, POSTMARKETING;
VACCINES, COMBINED;
|
EID: 0035893145
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/322562 Document Type: Conference Paper |
Times cited : (15)
|
References (13)
|